Financing, Equity Capital Markets

Dyne Therapeutics, Inc.

09/20
|
$267.7 Million
Piper Sandler served as bookrunner for Dyne Therapeutics Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma